When ‘Typically ≥99%’ Meets Real Research: What to Confirm Before a Reproducibility Review

A headline purity figure can look reassuring, but for laboratory researchers and materials managers preparing a reproducibility review, it is a prompt rather than a proof. The phrase “typically ≥99%” often appears in catalogue copy, FAQs and batch documentation. In HPLC terms it may refer to the area percentage of the main peak under a specific method. That is useful information, but it is not the same as full material characterisation. Before treating the number as a fixed property of a batch, confirm what was measured, how it was measured, and whether the figure belongs to the exact vial in front of you. Research Sciences publishes wording such as “≥99% Verified Purity” and states in its FAQ that peptides are typically supplied at ≥99% purity (HPLC tested), with exact purity stated on the CoA. Those are published claims to reconfirm against the live site and the batch CoA, not substitute evidence. All materials discussed here are research-use-only laboratory items, not for human or veterinary use.

What the ‘Typically ≥99%’ Figure Actually Represents

HPLC purity is usually reported by area normalisation at a chosen detection wavelength. Confirm the wavelength, column type, mobile phase, gradient, flow rate, injection volume, run time and integration parameters. The same sample can produce different area percentages under different chromatographic conditions, so “≥99%” is method-dependent. Ask whether the figure is a single injection result, an average, or a release specification. If the CoA gives only a summary, ask whether the underlying method and representative chromatogram are available. A number without its method is difficult to transfer into a reproducibility review.

Area percentage is not the same as mass purity

An HPLC area percentage may not capture water content, residual solvents, counterions, trace metals, endotoxin, or UV-invisible impurities. Confirm which tests are included for the batch. Research Sciences describes full-spectrum testing as purity, identity, heavy metals and endotoxin evaluation of submitted samples, but researchers should verify what the actual batch CoA reports rather than assuming every test appears on every certificate. Trace mannitol is described in the shop’s FAQ as an excipient; confirm whether it affects the assay, mass balance or reconstitution step in your in-vitro workflow. Also confirm identity: a purity figure without an identity result is incomplete evidence for a reproducibility file.

“Typically” is not a batch-specific result

The word typically signals a catalogue-level expectation, not a guarantee for every lot. Check whether the CoA states a specific value for that batch and whether the certificate is linked to the product you have received. Research Sciences uses vial label references that combine SKU and expiry, such as BPC10-03/27, linked to the corresponding CoA. Quote that reference when contacting the shop about documentation. Where an Internal Test Reference (ITR) appears, remember the FAQ position: a restocked product may carry the same ITR as earlier stock, and an ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or have had separate independent testing. Vial cap colours and packaging may vary and are not indicators of identity, analytical quality or manufacturing origin.

Documentation Checks That Turn a Headline Purity Claim into Reproducible Evidence

For a reproducibility review, the documentation should allow another laboratory to understand and, where appropriate, repeat the claim. Open the batch CoA and check that the product name, batch or ITR, label reference and expiry align with the vial. Confirm the CoA reports purity and identity and that the HPLC figure is not merely a catalogue headline repeated on a generic document. The shop’s homepage lists “CoAs Janoshik Analytical Reports”; treat that as published wording and open the CoA accompanying the specific batch. The FAQ states that every compound includes a CoA for purity and identity, and that materials are independently tested by HPLC and subject to final verification and quality checks in the UK before release. These are useful supplier statements, but the batch document remains the item to check.

If you are reviewing the current catalogue, start from Buy peptides to locate the relevant product page, then move to the individual batch CoA before comparing lots. This is particularly important when the review depends on cross-batch consistency. Do not rely on a cap colour, a product photograph or a previous order’s certificate. Record the CoA version, label reference and method details in the study file. Where heavy metals or endotoxin are relevant to the in-vitro model, confirm whether those results are present on the batch certificate. If a figure such as ≥99% is quoted in marketing text, attribute it to the shop’s current published wording and reconfirm it against the live page and the batch CoA.

Check the material, not just the certificate title

Confirm that the CoA relates to the correct product and form. Catalogue examples include Tesamorelin 5mg, TB-500 5mg, Ipamorelin 5mg, CJC-1295 (No DAC) 5mg, GHK-Cu 50mg and BPC-157 10mg, but the relevant product page and CoA should be checked individually. Research-use-only status must remain clear: materials are not medicines, medical devices, injectables, treatments or food supplements, and they are not for human or veterinary use. The purchaser is responsible for lawful use, safe handling, storage and disposal, including compliance with relevant UK regulations such as COSHH and laboratory safety standards, and for confirming suitability for the intended research application.

Reproducibility Review Questions for the Method, Material and Handling

Ask whether the HPLC method used for purity is described in enough detail to transfer. Confirm the column chemistry, dimensions, particle size, mobile-phase composition, gradient timetable, detection wavelength, column temperature, injection volume and integration rules. Ask how impurity peaks were counted and whether any peaks were excluded. If the CoA reports a single figure only, ask whether the corresponding method summary and chromatogram can be supplied. Without these details, a different laboratory may obtain a different area percentage even from the same material. The reproducibility review should distinguish between a supplier’s release result and an independently repeatable analytical result.

Handling conditions belong in the review file

Material handling can affect what the next analyst observes. Research Sciences guidance states that lyophilised peptides should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light, and that repeated freeze–thaw cycles should be avoided. Reconstituted peptides are described as less stable and should be stored at 2–8°C for short-term laboratory use. For in-vitro work, allow vials to reach ambient temperature before opening, work in a clean environment and remove only the amount required for the experiment. Reconstitution should be discussed only as a laboratory workflow step: confirm diluent volume and target concentration for the in-vitro assay. The free peptide reconstitution calculator is for laboratory research use only and must not be used for human or veterinary dosing.

Finally, confirm that the batch CoA is available before the reproducibility review begins, not after the study has started. Check that the document matches the vial reference, that the HPLC figure is tied to the correct batch, and that the method, identity result and relevant contaminant screening are present where required. If any item is missing, request it from the supplier before treating the purity figure as comparable across batches. Keep the research-use-only status prominent in the file: these materials are not for human or veterinary use, and all reconstitution and handling language should remain inside a controlled in-vitro laboratory workflow.